Benefits, pitfalls, and future design of population-based registers in neurodegenerative disease | Neurology
DIAGNOSIS OF EARLY ALZHEIMER'S DISEASE: CLINICAL PRACTICE IN 2021 • The Journal of Prevention of Alzheimer's Disease
Understanding neurodegeneration after traumatic brain injury: from mechanisms to clinical trials in dementia | Journal of Neurology, Neurosurgery & Psychiatry
CSF and Blood Biomarkers in Neuroinflammatory and Neurodegenerative Diseases: Implications for Treatment: Trends in Pharmacological Sciences
Practical recommendations for timely, accurate diagnosis of symptomatic Alzheimer's disease (MCI and dementia) in primary care: a review and synthesis - Liss - 2021 - Journal of Internal Medicine - Wiley Online Library
Understanding neurodegeneration after traumatic brain injury: from mechanisms to clinical trials in dementia | Journal of Neurology, Neurosurgery & Psychiatry
Molecular pathology of neurodegenerative diseases: principles and practice | Journal of Clinical Pathology
A Primary Care Agenda for Brain Health: A Scientific Statement From the American Heart Association | Stroke
Biomarkers for Alzheimer's disease: current status and prospects for the future - Blennow - 2018 - Journal of Internal Medicine - Wiley Online Library
Biology | Free Full-Text | Clinical Features of Parkinson's Disease: The Evolution of Critical Symptoms | HTML
Clinically accurate diagnosis of Alzheimer's disease via multiplexed sensing of core biomarkers in human plasma | Nature Communications
Frontiers | Bridging the Gap Between Fluid Biomarkers for Alzheimer's Disease, Model Systems, and Patients | Aging Neuroscience
Brain connectivity in neurodegenerative diseases—from phenotype to proteinopathy | Nature Reviews Neurology
University College London/University of Gothenburg PhD course “Biomarkers in neurodegenerative diseases” 2019—course organisation | Alzheimer's Research & Therapy | Full Text
Neurodegenerative disease - Wikipedia
Imaging biomarkers in neurodegeneration: current and future practices | Alzheimer's Research & Therapy | Full Text
RETISPEC AND TORONTO MEMORY PROGRAM AWARDED GRANT TO LAUNCH INNOVATIVE EARLY DETECTION PROGRAM FOR ALZHEIMER'S IN TORONTO, CANADA
Changes in Synaptic Proteins Precede Neurodegeneration Markers in Preclinical Alzheimer's Disease Cerebrospinal Fluid* - Molecular & Cellular Proteomics
Biomarkers for neurodegenerative diseases | Nature Medicine
Diagnosis of Alzheimer's disease utilizing amyloid and tau as fluid biomarkers | Experimental & Molecular Medicine
An update on blood-based biomarkers for non-Alzheimer neurodegenerative disorders | Nature Reviews Neurology
Shaping a data-driven era in dementia care pathway through computational neurology approaches | BMC Medicine | Full Text
Association between circadian rhythms and neurodegenerative diseases - The Lancet Neurology
Frontiers | Early Stages of Alzheimer's Disease: Evolving the Care Team for Optimal Patient Management | Neurology
Biomarkers for neurodegenerative diseases | Nature Medicine
